Herold-Mende C - Search Results

1

A PRDX1-p38α heterodimer amplifies MET-driven invasion of IDH-wildtype and IDH-mutant gliomas.

Wirthschaft P, Bode J, Simon AEM, Hoffmann E, van Laack R, Krüwel T, Dietrich F, Bucher D, Hahn A, Sahm F, Breckwoldt MO, Kurz FT, Hielscher T, Fischer B, Dross N, Ruiz de Almodovar C, von Deimling A, Herold-Mende C, Plass C, Boulant S, Wiestler B, Reifenberger G, Lichter P, Wick W, Tews B. Wirthschaft P, et al. Int J Cancer. 2018 Sep 1;143(5):1176-1187. doi: 10.1002/ijc.31404. Epub 2018 Apr 16. Int J Cancer. 2018. PMID: 29582423 Free article.

2

Clinical impact and functional aspects of tenascin-C expression during glioma progression.

Herold-Mende C, Mueller MM, Bonsanto MM, Schmitt HP, Kunze S, Steiner HH. Herold-Mende C, et al. Int J Cancer. 2002 Mar 20;98(3):362-9. doi: 10.1002/ijc.10233. Int J Cancer. 2002. PMID: 11920587 Free article.

3

Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck.

Ninck S, Reisser C, Dyckhoff G, Helmke B, Bauer H, Herold-Mende C. Ninck S, et al. Int J Cancer. 2003 Aug 10;106(1):34-44. doi: 10.1002/ijc.11188. Int J Cancer. 2003. PMID: 12794754 Free article.

4

Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing.

Herrero Y Calle M, Cornelis JJ, Herold-Mende C, Rommelaere J, Schlehofer JR, Geletneky K. Herrero Y Calle M, et al. Int J Cancer. 2004 Mar;109(1):76-84. doi: 10.1002/ijc.11626. Int J Cancer. 2004. PMID: 14735471 Free article.

5

Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis.

Beckhove P, Helmke BM, Ziouta Y, Bucur M, Dörner W, Mogler C, Dyckhoff G, Herold-Mende C. Beckhove P, et al. Clin Cancer Res. 2005 Apr 15;11(8):2899-906. doi: 10.1158/1078-0432.CCR-04-0664. Clin Cancer Res. 2005. PMID: 15837740

6

Different angiogenic phenotypes in primary and secondary glioblastomas.

Karcher S, Steiner HH, Ahmadi R, Zoubaa S, Vasvari G, Bauer H, Unterberg A, Herold-Mende C. Karcher S, et al. Int J Cancer. 2006 May 1;118(9):2182-9. doi: 10.1002/ijc.21648. Int J Cancer. 2006. PMID: 16331629 Free article.

7

Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activity in vitro and in vivo.

Vasvari GP, Dyckhoff G, Kashfi F, Lemke B, Lohr J, Helmke BM, Schirrmacher V, Plinkert PK, Beckhove P, Herold-Mende CC. Vasvari GP, et al. Int J Cancer. 2007 Oct 15;121(8):1697-704. doi: 10.1002/ijc.22867. Int J Cancer. 2007. PMID: 17557286 Free article.

8

Basal caspase activity promotes migration and invasiveness in glioblastoma cells.

Gdynia G, Grund K, Eckert A, Böck BC, Funke B, Macher-Goeppinger S, Sieber S, Herold-Mende C, Wiestler B, Wiestler OD, Roth W. Gdynia G, et al. Mol Cancer Res. 2007 Dec;5(12):1232-40. doi: 10.1158/1541-7786.MCR-07-0343. Mol Cancer Res. 2007. PMID: 18171980

9

Stem cell marker CD133 affects clinical outcome in glioma patients.

Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende CC. Zeppernick F, et al. Clin Cancer Res. 2008 Jan 1;14(1):123-9. doi: 10.1158/1078-0432.CCR-07-0932. Clin Cancer Res. 2008. PMID: 18172261

10

Yes and PI3K bind CD95 to signal invasion of glioblastoma.

Kleber S, Sancho-Martinez I, Wiestler B, Beisel A, Gieffers C, Hill O, Thiemann M, Mueller W, Sykora J, Kuhn A, Schreglmann N, Letellier E, Zuliani C, Klussmann S, Teodorczyk M, Gröne HJ, Ganten TM, Sültmann H, Tüttenberg J, von Deimling A, Regnier-Vigouroux A, Herold-Mende C, Martin-Villalba A. Kleber S, et al. Cancer Cell. 2008 Mar;13(3):235-48. doi: 10.1016/j.ccr.2008.02.003. Cancer Cell. 2008. PMID: 18328427 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

402 results

Search Page